IQuity Labs Inc.'s plan to apply its new machine learning-based data mining and analytics platform to the early detection of Alzheimer's disease has earned the endorsement of the US National Institutes of Health. In September, NIH's National Institute on Aging (NIA) awarded the company a $320,000 supplemental grant to help get the project going.
"This is the foundation. This is the first set of building blocks that we're going to put on the board to go after this problem," iQuity CEO Chase Spurlock told Medtech Insight. "We're very humbled by the NIH's support
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?